Director of Fibrosis, Renal and Cardiovascular Research
Dr. Genovese joined Nordic Bioscience in 2011 and from 2014 she leads a group working in the application of markers of ECM remodeling in kidney and cardiovascular diseases. Her group’s activities span from biomarker discovery and development to clinical and preclinical biomarker validation in several chronic kidney diseases (CKD, DKD, IgAN, ADPKD, kidney transplant) and cardiovascular diseases (HFpEF, atherosclerosis, myocardial infarction, atrial fibrillation).
H-index: 21. i10-index: 34. Citations: 1954